Ma J - Search Results

1

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer.

Ge W, Shentu D, Wang Y, Wang Y, Xue S, Yue M, Mao T, Zhang X, Xu H, Li S, Ma J, Yao J, Cui J, Wang L. Ge W, et al. Among authors: ma j. Front Cell Dev Biol. 2022 Oct 6;10:1001606. doi: 10.3389/fcell.2022.1001606. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36274838 Free PMC article.

2

Characterization of DNA damage response deficiency in pancreatic cancer patients from China.

Zhang X, Mao T, Zhang B, Xu H, Cui J, Jiao F, Chen D, Wang Y, Hu J, Xia Q, Li S, Yue M, Ma J, Yao J, Wang Y, Zhang X, Chen S, Bai Y, Wang Y, Zhang X, Liu Q, Sun Y, Fu D, Liu Y, Xiong L, Wang L. Zhang X, et al. Among authors: ma j. Cancer Commun (Lond). 2022 Jan;42(1):70-74. doi: 10.1002/cac2.12238. Epub 2021 Nov 24. Cancer Commun (Lond). 2022. PMID: 34821074 Free PMC article. No abstract available.

3

Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer.

Zhang X, Mao T, Zhang B, Xu H, Cui J, Jiao F, Chen D, Wang Y, Hu J, Xia Q, Ge W, Li S, Yue M, Ma J, Yao J, Wang Y, Wang Y, Shentu D, Zhang X, Chen S, Bai Y, Wang Y, Zhang X, Liu Q, Sun Y, Fu D, Liu Y, Xiong L, Wang L. Zhang X, et al. Among authors: ma j. EBioMedicine. 2022 Mar;77:103897. doi: 10.1016/j.ebiom.2022.103897. Epub 2022 Feb 26. EBioMedicine. 2022. PMID: 35231699 Free PMC article.

4

Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer.

Zhang X, Mao T, Xu H, Li S, Yue M, Ma J, Yao J, Wang Y, Zhang X, Ge W, Wang Y, Shentu D, Wang L. Zhang X, et al. Among authors: ma j. Aging (Albany NY). 2022 Apr 25;14(8):3597-3606. doi: 10.18632/aging.204031. Epub 2022 Apr 25. Aging (Albany NY). 2022. PMID: 35468095 Free PMC article.

5

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer.

Ge W, Ma J, Mao T, Xu H, Zhang X, Li S, Wang Y, Yao J, Yue M, Jiao F, Wang Y, Zhuo M, Han T, Hu J, Zhang X, Cui J, Wang L. Ge W, et al. Among authors: ma j. Front Oncol. 2022 Jun 8;12:890715. doi: 10.3389/fonc.2022.890715. eCollection 2022. Front Oncol. 2022. PMID: 35756644 Free PMC article.

6

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma.

Xue S, Ge W, Wang K, Mao T, Zhang X, Xu H, Wang Y, Yao J, Li S, Yue M, Ma J, Wang Y, Shentu D, Cui J, Wang L. Xue S, et al. Among authors: ma j. Front Cell Dev Biol. 2022 Aug 8;10:942225. doi: 10.3389/fcell.2022.942225. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36003146 Free PMC article.

7

HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53.

Mao T, Zhang X, Xu H, Zhang X, Ge W, Li S, Ma J, Yue M, Xue S, Cui J, Wang L. Mao T, et al. Among authors: ma j. Cancer Cell Int. 2022 Dec 1;22(1):380. doi: 10.1186/s12935-022-02807-4. Cancer Cell Int. 2022. PMID: 36457011 Free PMC article.

8

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.

Ge W, Yue M, Wang Y, Wang Y, Xue S, Shentu D, Mao T, Zhang X, Xu H, Li S, Ma J, Wang L, Cui J. Ge W, et al. Among authors: ma j. Int J Mol Sci. 2022 Dec 21;24(1):156. doi: 10.3390/ijms24010156. Int J Mol Sci. 2022. PMID: 36613599 Free PMC article.

9

PLA2G2A⁺ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8⁺ cytotoxic T cells.

Ge W, Yue M, Lin R, Zhou T, Xu H, Wang Y, Mao T, Li S, Wu X, Zhang X, Wang Y, Ma J, Wang Y, Xue S, Shentu D, Cui J, Wang L. Ge W, et al. Among authors: ma j. Cancer Lett. 2023 Apr 1;558:216095. doi: 10.1016/j.canlet.2023.216095. Epub 2023 Feb 14. Cancer Lett. 2023. PMID: 36796670 Free article.

10

Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer.

Li S, Yue M, Xu H, Zhang X, Mao T, Quan M, Ma J, Wang Y, Ge W, Wang Y, Xue S, Shentu D, Cui J, Wang L. Li S, et al. Among authors: ma j. Cancer Lett. 2023 Jun 28;564:216206. doi: 10.1016/j.canlet.2023.216206. Epub 2023 Apr 28. Cancer Lett. 2023. PMID: 37120007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,512 results

Search Page

Filters